Clinical Trial Update: Atorvastatin Reduces Chronic Inflammation and aVerage Epogen Dose (ARChIVED) [NA]

View source ↗

Summary

The ARChIVED trial investigating atorvastatin to reduce chronic inflammation and Epogen dose in patients with complications of renal dialysis has been withdrawn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complication of Renal Dialysis

Drugs mentioned

• Epogen (epoetin alfa)
• Lipitor (atorvastatin)

Snippet

Sponsor: Albert Einstein Healthcare Network | Conditions: Complication of Renal Dialysis | NA | Status: WITHDRAWN